Results 121 to 130 of about 2,486 (168)

Endarteritis obliterans or Arteriosclerosis obliterans?

Pathologia et Microbiologia, 2008
A, Kádár, H, Jellinek, Z, Béres
openaire   +2 more sources

HISTAMINE IN ARTERIOSCLEROSIS OBLITERANS

Journal of the American Medical Association, 1949
To the Editor:— In the December 4 issue ofThe Journal, page 1036, Friedell, Drucker and Pickett reported favorably on the treatment of arteriosclerosis obliterans with histidine and ascorbic acid. Good results from this therapy had previously been reported by Wirtschafter and Widmann, who suggested that the effects were due to the elaboration of ...
openaire   +1 more source

Arteriosclerosis obliterans.

Postgraduate medicine
Preview With improvement in noninvasive assessment methods in recent years, therapeutic options for arteriosclerosis obliterans have expanded. Much can be done to control symptoms of intermittent claudication and improve overall functioning before angioplasty or bypass surgery need be considered. Here Drs Ku and Nagler discuss the options in evaluation
Aubrey, Ku, Willibald, Nagler
openaire   +1 more source

[Arteriosclerosis obliterans (ASO)].

Nihon rinsho. Japanese journal of clinical medicine, 2010
The goal of treatment in arteriosclerosis obliterans (ASO) is to aggressively treat atherosclerotic risk factors to reduce future cardiovascular events as well as to improve symptoms of claudication and prevent limb amputation. Patients with ASO have an increased risk of cardiovascular events such as myocardial infarction and stroke in addition to ...
Megumi, Koshikawa, Uichi, Ikeda
openaire   +1 more source

Thromboangiitis Obliterans and Arteriosclerosis Obliterans

Annals of Internal Medicine, 1963
J R, MCPHERSON, J L, JUERGENS, R W, GIFFORD   +2 more
openaire   +2 more sources

[Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans].

Fortschritte der Medizin, 1989
In a pilot study the therapeutic effect of 2 x 500 mg etofibrate (Lipo Merz retard) on lipids and lipoproteins, fibrinolytic activity and clinical parameters was studied for four weeks in hyperlipidemic patients suffering from arteriosclerosis obliterans (Fontaine stage II/III).
A, Dembińska-Kieć, E, Kostka-Trabka, L, Grodzińska, K, Bieroń, A, Kedzior, M, Basista, A, Zmuda, E, Trabka, M, Slawiński, H, Czarnecka   +9 more
openaire   +1 more source

[Pathology of arteriosclerosis obliterans].

Nihon Geka Gakkai zasshi, 1996
Pathomorphological aspects of arteriosclerosis obliterans were reviewed. While the morphology is basically atherosclerosis, complete occlusions by fresh or old thrombi are often observed. Obstruction with lipid-poor fibrous tissue is also recognized.
openaire   +1 more source

Clinical arteriosclerosis obliterans

The American Journal of Surgery, 1958
openaire   +2 more sources

ARTERIOSCLEROSIS OBLITERANS; AN EPITOME†

Journal of the American Geriatrics Society, 1959
openaire   +2 more sources

Arteriosclerosis obliterans

Postgraduate Medicine, 1995
A, Ku, W, Nagler
openaire   +2 more sources